LONDON – Paul Hastings LLP, a leading global law firm, announced today that it advised DexCom, Inc., a leading provider of continuous glucose monitoring technology to both patients and healthcare professionals, on its recent acquisition of Nintamed, a distribution company with presence in Germany, Switzerland and Austria. Nintamed has served as Dexcom's exclusive distributor in these countries for six years.
The Paul Hastings team comprised partner Ronan O’Sullivan and senior associate Matthew Poxon in London, partner Regina Engelstädter and associate Maximilian Kuhn in Frankfurt, and partner Teri O’Brien in San Diego.
At Paul Hastings, our purpose is clear — to help our clients and people navigate new paths to growth. With a strong presence throughout Asia, Europe, Latin America, and the U.S., Paul Hastings is recognized as one of the world’s most innovative global law firms.